Joanne Edwards

Citat de

	Toate	Din 2020
Referințe bibliografice	18417	7965
h-index	71	43
i10-index	219	152

1700

850

425

1275

20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025102 118 82 95 115 157 166 196 255 254 378 436 563 787 855 901 1043 1020 1019 1087 1284 1542 1617 1604 1605 300

Acces public

Afișați-le pe toate

119 articole

2 articole

disponibile

indisponibile

Pe baza cerințelor privind finanțarea

Coautori

Donald C McMillanProfessor of Surgical Science, University of GlasgowAdresă de e-mail confirmată pe glasgow.ac.uk
Paul G Horgan PhD FRCSSt Mungo Professor of Surgery, University of GlasgowAdresă de e-mail confirmată pe glasgow.ac.uk
John BartlettDirector of Transformative Pathology, Ontario Institute for Cancer ResearchAdresă de e-mail confirmată pe oicr.on.ca
Antonia K RoseweirLecturerAdresă de e-mail confirmată pe glasgow.ac.uk
Campbell RoxburghUniversity Department of Surgery, Glasgow Royal InfirmaryAdresă de e-mail confirmată pe glasgow.ac.uk
Going, James J.Consultant Histopathologist, GlasgowAdresă de e-mail confirmată pe udcf.gla.ac.uk
James H. ParkClinical Lecturer in Colorectal Surgery, University of GlasgowAdresă de e-mail confirmată pe glasgow.ac.uk
Jean A QuinnResearch Associate, University of GlasgowAdresă de e-mail confirmată pe glasgow.ac.uk
Arfon G M T Powell PhD FRCSConsultant Oesophagogastric & General SurgeonAdresă de e-mail confirmată pe nca.nhs.uk
pamela mccallUniversity of glasgowAdresă de e-mail confirmată pe glasgow.ac.uk
Kathryn PennelUniversity of GlasgowAdresă de e-mail confirmată pe glasgow.ac.uk
Hester van WykUniversity of GlasgowAdresă de e-mail confirmată pe gla.ac.uk
Liane McGlynnUniversity of Glasgow, Institute of Cancer SciencesAdresă de e-mail confirmată pe glasgow.ac.uk
Lindsay BennettNHS Greater Glasgow & ClydeAdresă de e-mail confirmată pe ggc.scot.nhs.uk
Karen BlythCRUK Beatson InstituteAdresă de e-mail confirmată pe beatson.gla.ac.uk
Stephen T McSorleyClinical Lecturer, General Surgery, University of GlasgowAdresă de e-mail confirmată pe doctors.org.uk
Nigel B JamiesonProfessor of Surgery and Consultant HPB Surgeon, Glasgow UniversityAdresă de e-mail confirmată pe glasgow.ac.uk
Rachana PatelCRUK Beatson InstituteAdresă de e-mail confirmată pe beatson.gla.ac.uk
Zhiyong GuoUniversity of MarylandAdresă de e-mail confirmată pe umaryland.edu
Tove KirkegaardKirurgisk Afdeling, Køge og Roskilde Sygehus, ForskningskoordinatorAdresă de e-mail confirmată pe tovekirkegaard.dk

Urmăriți

Joanne Edwards

Professor of Translational Pathology, University of Glasgow

Adresă de e-mail confirmată pe glasgow.ac.uk

cancer biomarkers


Titlu Sortați după descrierea bibliografică Sortați după an Sortați după titlu	Citat de Citat de	Anul
A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion–resistant growth Z Guo, X Yang, F Sun, R Jiang, DE Linn, H Chen, H Chen, X Kong, ... Cancer research 69 (6), 2305-2313, 2009	1107	2009
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism C Sebastián, BMM Zwaans, DM Silberman, M Gymrek, A Goren, L Zhong, ... Cell 151 (6), 1185-1199, 2012	733	2012
Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer R Hu, C Lu, EA Mostaghel, S Yegnasubramanian, M Gurel, C Tannahill, ... Cancer research 72 (14), 3457-3462, 2012	667	2012
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, ... Breast Cancer Research 15, 1-37, 2013	541	2013
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana K Mayer, C Schüller, R Wambutt, G Murphy, G Volckaert, T Pohl, ... Nature 402 (6763), 769-777, 1999	488	1999
Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer J Edwards, NS Krishna, KM Grigor, JMS Bartlett British journal of cancer 89 (3), 552-556, 2003	487	2003
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022	429*	2022
Mannose impairs tumour growth and enhances chemotherapy PS Gonzalez, J O’Prey, S Cardaci, VJA Barthet, J Sakamaki, F Beaumatin, ... Nature 563 (7733), 719-723, 2018	404	2018
Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study E Kirmeier, LI Eriksson, H Lewald, MJ Fagerlund, A Hoeft, M Hollmann, ... The Lancet Respiratory Medicine 7 (2), 129-140, 2019	351	2019
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021	282	2021
Successful treatment of primary amebic meningoencephalitis JS Seidel, P Harmatz, GS Visvesvara, A Cohen, J Edwards, J Turner New England Journal of Medicine 306 (6), 346-348, 1982	281	1982
Observer variation in immunohistochemical analysis of protein expression, time for a change? T Kirkegaard, J Edwards, S Tovey, LM McGlynn, SN Krishna, ... Histopathology 48 (7), 787-794, 2006	268	2006
Gene amplifications associated with the development of hormone-resistant prostate cancer J Edwards, NS Krishna, CJ Witton, JMS Bartlett Clinical cancer research 9 (14), 5271-5281, 2003	264	2003
NF-κB pathways in the development and progression of colorectal cancer M Patel, PG Horgan, DC McMillan, J Edwards Translational Research 197, 43-56, 2018	260	2018
COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing T Peto, D Affron, B Afrough, A Agasu, M Ainsworth, A Allanson, K Allen, ... EClinicalMedicine 36, 2021	217	2021
Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer L Tam, LM McGlynn, P Traynor, R Mukherjee, JMS Bartlett, J Edwards British journal of cancer 97 (3), 378-383, 2007	205	2007
MCL-1 is a prognostic indicator and drug target in breast cancer KJ Campbell, S Dhayade, N Ferrari, AH Sims, E Johnson, SM Mason, ... Cell death & disease 9 (2), 19, 2018	200	2018
High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of … C Watson, JS Long, C Orange, CL Tannahill, E Mallon, LM McGlynn, ... The American journal of pathology 177 (5), 2205-2215, 2010	199	2010
The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast … Z Mohammed, JJ Going, J Edwards, B Elsberger, JC Doughty, ... British journal of cancer 107 (5), 864-873, 2012	181	2012
Is PTEN loss associated with clinical outcome measures in human prostate cancer? P McCall, CJ Witton, S Grimsley, KV Nielsen, J Edwards British journal of cancer 99 (8), 1296-1301, 2008	180	2008

Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.

Articole 1–20

Referințe bibliografice pe an

Citate duplicat

Citate fuzionate

Adăugați coautoriCoautori

Urmăriți

Citat de

Coautori